Literature DB >> 6330991

Studies with inhibitors of oligosaccharide processing indicate a functional role for complex sugars in the transport and proteolysis of Friend mink cell focus-inducing murine leukemia virus envelope proteins.

A Pinter, W J Honnen, J S Li.   

Abstract

The functions of asparagine-linked oligosaccharides on the PrENV protein of Friend mink cell focus-inducing (FrMCF-1) murine leukemia virus were investigated by examining the effect of two inhibitors of different stages of the biosynthetic pathway of these sugar substituents on the synthesis and processing of the viral proteins. Treatment of virus-producing cells with tunicamycin totally inhibited the glycosylation of PrEnv, and resulted in the formation of a nonglycosylated form of the protein of molecular weight 62 kDa. This component was not proteolytically processed inside the cells, and neither it nor any derivative proteins were incorporated into extracellular virions. Treatment of cells with 1-deoxynojirimycin (DNM), which inhibits the cellular glucosidases normally involved in removal of the three glucose residues present on the initially transferred oligosaccharide chains, resulted in the intracellular accumulation of a slightly larger than normal form of PrENV, and decreased levels of cell-associated gp70. Only gp70 was detected on the cell surface. The bulk of the gp70 produced in the presence of the drug was aberrantly glycosylated, and contained decreased levels of complex and increased numbers of high mannose oligosaccharides; almost all of the gp70 molecules however, contained at least one complex sugar chain. Decreased incorporation of both env and gag proteins into extracellular virions was observed, despite the fact that the gag proteins were processed normally intracellularly; in contrast, DNM treatment of Gazdar murine sarcoma virus-infected HTG2 cells, which produce only gag but not env proteins, did not inhibit the release of extracellular virus. Ultrastructural examination of FrMCF-infected cells treated with DNM indicated the presence of large numbers of intracytoplasmic vacuoles, many of which contained viral particles. These studies indicate that the normal maturation process involved in the formation of complex oligosaccharides is necessary to obtain efficient transport to the plasma membrane and proteolysis of PrEnv, and also provide evidence suggesting a role for the env proteins in regulating assembly of gag proteins into virions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6330991     DOI: 10.1016/0042-6822(84)90259-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  O-linked glycosylation of retroviral envelope gene products.

Authors:  A Pinter; W J Honnen
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  A deletion in the Friend spleen focus-forming virus env gene is necessary for its product (gp55) to be leukemogenic.

Authors:  N Watanabe; M Nishi; Y Ikawa; H Amanuma
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

3.  Comprehensive mutational analysis of the Moloney murine leukemia virus envelope protein.

Authors:  S M Rothenberg; M N Olsen; L C Laurent; R A Crowley; P O Brown
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 4.  How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum.

Authors:  A Helenius
Journal:  Mol Biol Cell       Date:  1994-03       Impact factor: 4.138

5.  Expression of the protein product of the mouse mammary tumor virus long terminal repeat gene in phorbol ester-treated mouse T-cell-leukemia cells.

Authors:  J Racevskis
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

6.  Synthesis, assembly, and processing of the Env ERVWE1/syncytin human endogenous retroviral envelope.

Authors:  V Cheynet; A Ruggieri; G Oriol; J-L Blond; B Boson; L Vachot; B Verrier; F-L Cosset; F Mallet
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.

Authors:  P B Fischer; M Collin; G B Karlsson; W James; T D Butters; S J Davis; S Gordon; R A Dwek; F M Platt
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

8.  Presentation of native epitopes in the V1/V2 and V3 regions of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains.

Authors:  S C Kayman; Z Wu; K Revesz; H Chen; R Kopelman; A Pinter
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

9.  Mutational analysis of N-linked glycosylation sites of Friend murine leukemia virus envelope protein.

Authors:  S C Kayman; R Kopelman; S Projan; D M Kinney; A Pinter
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

10.  Reconstitution of the ancestral glycoprotein of human endogenous retrovirus k and modulation of its functional activity by truncation of the cytoplasmic domain.

Authors:  Kirsten Hanke; Philipp Kramer; Sandra Seeher; Nadine Beimforde; Reinhard Kurth; Norbert Bannert
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.